-
March 13 PS market morning review
Time of Update: 2022-12-09
Yesterday, the PS market continued to fall and the trading atmosphere was flat.
Yesterday, the PS market continued to fall and the trading atmosphere was flat.
Yesterday, the PS market continued to fall and the trading atmosphere was flat.
-
J Clin Oncol: Neoadjuvant Nivolumab/Ipilimumab + Adjuvant Nivolumab in dMMR/MSI-H Gastric/Gastroesophageal Junction Adenocarcinoma
Time of Update: 2022-10-15
In conclusion, for patients with dMMR/MSI-H resectable gastric/gastroesophageal junction adenocarcinoma, nivolumab- and ipilimumab-based neoadjuvant therapy is feasible, with a high pathological complete response rate and no Unexpected toxicity .
-
Universal "modular" CAR-T: Innovent continues to develop cell therapy
Time of Update: 2022-05-24
In this collaboration, Innovent can develop 2:1 bispecific T-cell antibodies and general-purpose CAR-T therapy for hematological and solid tumor treatment using Roche's patented technology, and is responsible for product development, manufacturing and commercialization , the specific transaction amount was not disclosed .
-
New drugs for prostate cancer are 80% effective
Time of Update: 2021-12-01
Innovation Connection RussiaThe Russian National Research University "Moscow State Institute of Steel and Alloys" announced that a team of scientists from Russia's leading universities has developed drugs for the treatment of prostate cancer with a treatment efficiency of 80% .
-
The effect of coating thickness on coating quality
Time of Update: 2020-12-03
For coatings with high viscosity, the coating film is too thin, then poor leveling is prone to dry roughness, the coating film is too thick, it is not possible to ensure that the surface loses fluidity before the micro-bubble escape, thus forming dark bubbles, tweezers and other ills.
-
Pediatric drug market and cross-border cooperation trends (International Part 1
Time of Update: 2020-09-07
Chart XII: Comparison of clinical research distribution (by clinical stage) carried out by Chinese and foreign enterprises in China, the clinical design of pediatrics is complex, and patient recruitment is facing great challenges Despite the gratifying results achieved by the implementation of the laws and regulations on the development of paediatric drugs, the market demand for paediatric drugs is far from being met.
-
Do you want to eat first or have soup first? Dietitians reveal dietary steps for 4 major cancer patients
Time of Update: 2020-08-19
Cancer patients who are afraid to drink only nutritional products: It is recommended to use nutrients to match natural foods on the basis, such as using a balanced nutritional formula to stir fruit into fruit juice milk, or concentrate the formula to make a milkshake, milk freeze or pudding snacks.
-
Competition in the field of migraine intensifies! The fourth CGRP targeting antibody-Lingbei Vyepti was approved by the US FDA for intravenous infusion every 3 months
Time of Update: 2020-02-23
February 23, 2020 / BIOON / -- lundbeck recently announced that the U.S Food and Drug Administration (FDA) has approved vyepti (eptinezumab jjmr) for the preventive treatment of adult migraine It is w
-
The prospect of Biopharmaceutics is broad, and the overseas distribution of China still needs to be strengthened
Time of Update: 2018-11-20
[China Pharmaceutical network industry trends] recently, the literature and information center of the Chinese Academy of Sciences and the American Chemical Abstracts Agency jointly released the resear
-
Comparison of advantages between automatic decoction machine and traditional decoction method
Time of Update: 2018-09-07
Traditional Chinese medicine is the cultural treasure of the Chinese nation Its unique efficacy and fewer side effects are highly praised by the patients all over the world However, the decoction meth
-
Yushengtang group signs intent agreement to acquire Japanese pharmaceutical enterprises
Time of Update: 2010-05-17
"Jinhua Qinggan" has entered the global market Beijing Yushengtang Pharmaceutical Group (01141, HK), a 400 year old traditional Chinese medicine brand, has recently made a big move, announcing that it
